Introduction
Recent advances in the study of cerebrospinal fluid (CSF) in demyelinating diseases ofthe nervous system may now lead to some improvements in diagnosis and prognostication. The most common demyelinating disease of the human nervous system is multiple sclerosis (MS), which has a prevalence rate of over 30 per 100,000 in high frequency areas such as the United Kingdom.' First described separately by a Scotsman and a Frenchman-3 the diagnosis is still made largely on clinical criteria, but now supplemented with information from cerebrospinal fluid (CSF) immunoglobulins. 4 The Guillain-Barre syndrome (GBS) with an incidence rate of 1:100,000 is an acute peripheral demyelinating disorder that is diagnosed clinically,5 with CSF cell and protein features that may strongly support the diagnosis. These two disorders exemplify the value ofCSF analysis in the diagnosis ofdemyelinating diseases.
In the context of MS and GBS, lumbar puncture is relatively safe: the temporary post-lumbar puncture symptoms of headache, nausea, vomiting and low back pain occur in less than one third of all patients.6'7 Occasionally, the GBS is associated with intracranial hypertension and papilloedema. In this situation, the lumbar puncture is preferably performed after a computed tomographic (CT) scan (to exclude an unsuspected intracranial pathology) and in liaison with neurosurgical colleagues in case of subsequent clinical deterioration. The reader is referred to a standard text for details of the correct procedure to obtain CSF by diagnostic lumbar puncture.'
Normal ranges for many CSF components are described in this review, but there will be slight variation between laboratories because different methods are used. Furthermore, the patient's blood must always be examined to differentiate the CSF changes that are independent of blood (which occur in MS and GBS) from the systemic changes that occur in systemic infections and gammopathies.8 Abnormal CSF immunoglobulins are of great value in demyelinating disorders, but only when normal in the patient's blood. An occasional traumatic lumbar puncture will occur even with the best techniques, and this prohibits reliable diagnostic information. In these circumstances, a repeat examination may be considered after 3-10 days, by which time the changes secondary to the blood leakage should have resolved. For Further comparison of OB and immunoglobulin light chains in MS with other diseases in serial samples may extend the specificity of the temporal invariance of OB noted in MS.
Having established clear evidence of subclinical disease, it will be important to investigate whether the CSF immunoglobulin abnormalities precede the pathological lesions (as identified by magnetic resonance imaging). If this were so, attempts to block such antibodies might be more strongly justified at a therapeutic procedure. 
